Zentalis Pharmaceuticals, Inc.
$336.07M- Market cap
- $287.40M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.98x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.26x
$4.01Latest market snapshot
Implied fair value · at TMUS's multiple
$2.0748.3% below market
0.94 ZNTL revenue / share×2.21x TMUS P/S=$2.07
Market $4.01Implied $2.07
TMUS · current priceP/S 2.21x
$181.55Latest market snapshot
Implied fair value · at ZNTL's multiple
$350.9293.3% above market
82.33 TMUS revenue / share×4.26x ZNTL P/S=$350.92
Market $181.55Implied $350.92